The Agency That Learned to Translate Science

The difficult thing about explaining medicine is that every simplification contains a small temptation. Remove enough detail and the story becomes vivid but wrong. Keep every qualification and the audience quietly leaves the room. Strategic Partners Group built a business in that uncomfortable space between accuracy and attention.

The company was formed in Gurugram around a specialist idea. Its founders, Aman Gupta and Shivani Gupta, saw that healthcare, pharmaceuticals and life sciences were being handled like ordinary consumer categories. They were not ordinary. A drug launch might need clinicians to trust the evidence, patients to understand the benefit, policymakers to see the public value and journalists to believe that the story was more than promotion. One brief could contain four different languages.

The niche was the growth engine

SPAG, the group's public-relations and advocacy agency, became the sharp end of the business. Its work stretched from scientific communications and media relations to public affairs, policy dialogue, stakeholder engagement and crisis counsel. This was less about producing press releases than learning how decisions travel: from a laboratory to a regulator, from a hospital to a newsroom, from a patient group to a legislature.

The specialist position quickly produced proof. Early assignments included Abbott, Novartis, Sanofi, Baxter, AdvaMed and PhRMA, alongside the Bill & Melinda Gates Foundation and other public-health organizations. In 2015, SPAG was named Global New Agency of the Year at the SABRE Awards. That same year it won the communications mandate for the announcement of India's FIFA U-17 World Cup - evidence that a health-led shop could carry its method into a national sporting event.

An industry profile from that growth period put revenue at about $2.15 million. The number is less revealing than the sequence behind it. SPAG did not begin as a general agency and later invent a healthcare practice. It began with the difficult practice, earned credibility there and then moved sideways.

“Look beyond the obvious and don't be afraid of taking risks.”Aman Gupta, on the instinct behind the work

The elephant in the second room

The first thing to become inadequate was the old “message-bearer” role. The group's own retrospective describes a pivot from carrying announcements to helping patients act, shaping policy conversations and building campaigns from evidence and lived experience. Technology pushed the change; the pandemic made it unavoidable. Once audiences, clinicians and employees were all meeting through screens, digital could no longer be the department invited in after the strategy was finished.

The sideways move had an unusually memorable name: D Yellow Elephant. It was the group's digital and social specialist, covering analytics, strategy, design, development, content, media and influencer work. The arrangement made organizational sense. SPAG could understand the policy room; D Yellow Elephant could understand the phone screen. Increasingly, clients needed the same idea to survive in both.

Healthcare made that integration urgent. During the pandemic, brands shifted spending toward digital channels, while internal culture, patient education and professional engagement all had to work without the usual physical settings. The group's Culture Connect program for Becton Dickinson used digital communications to support an internal transformation and collected SABRE and PRCA SEA recognition. D Yellow Elephant's Unhide Psoriasis campaign had already been commended at the 2019 PRCA Southeast Asia Awards. The work was a demonstration of the model: subject sensitivity first, format second.

Local context became the product

Asia is often written as if it were a single market with many airports. SPAG expanded on the opposite assumption. It established a Singapore presence in 2019, entered Malaysia in 2020 and built reach through India, Southeast Asia and Greater China. The commodity was not simply access to those places. It was the ability to know when an idea that worked in Delhi would sound strange in Singapore, or when a regional message needed to be rebuilt rather than translated.

That distinction explains the customer list. Pharmaceutical and medical-device companies use the agency when the reputational, regulatory and scientific details cannot be handed to a generic campaign machine. Technology, consumer, travel and purpose-led organizations use it for the same underlying reason: they have several audiences, uneven context and little room for a clumsy first impression. The business model is the familiar agency mix of retained counsel and project fees. The less familiar part is what sits inside the billable hour - research, sector knowledge and local judgment.

The deal made the map larger

On July 18, 2022, SPAG joined FINN Partners. The price was not disclosed. The strategic exchange was easier to see. FINN gained a substantial Asian healthcare platform; SPAG gained a global network with research, creative, digital and medical-content depth. Founders Aman and Shivani Gupta remained in leadership. The operating identity became SPAG/FINN Partners.

Acquisitions can erase the very distinction that made a firm worth buying. Here, the surviving signals matter. The agency still organizes itself around health and other knowledge-heavy sectors. It still presents local market judgment as a capability. Even the compact cultural instruction - “Work hard. Play nice.” - remains in place. In 2024, PRovoke Media reported that the combined Asian health practice had grown 18 percent in the prior year. Campaign recognition followed for AstraZeneca, Bayer, Roche and others in 2025.

There is a condition attached to that playbook. Specialization works when clients value the cost of getting a nuance wrong. It is less persuasive in low-stakes, price-led categories where speed and cheap distribution dominate. It also fails if expertise becomes a costume: a few technical nouns pasted onto an ordinary pitch. SPAG's advantage came from staffing and organizing around the subject, then letting creative and digital execution follow.

The larger lesson is almost comic in its simplicity. Many agencies try to become interesting by speaking more loudly. Strategic Partners Group became useful by listening long enough to understand what could safely be said. In a business devoted to messages, its edge was the work that happened before the message.